EU TRANSPARENCY REGISTER · 433002037182-07 · United States

Haemonetics S.A.

HAE SA

Category

Companies & groups

Country

United States

Boston

Entity form

Company limited by shares (AG)

Stated objectives

A Global Healthcare Company Dedicated to Providing a Suite of Innovative Hematology Products and Solutions Our comprehensive portfolio of devices, information management, and consulting services offers blood management solutions for each fa…

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2020-01-31

Last updated

2025-10-02

Other Companies & groups in United States

Other registered organisations in United States

Frequently asked questions

What is this organisation?
Haemonetics S.A. (HAE SA) is an interest representative listed in the EU Joint Transparency Register under ID 433002037182-07. Entity form: Company limited by shares (AG).
What category is it registered under?
It is registered under the category "Companies & groups".
Which country is it based in?
The organisation is based in United States, Boston.
What are its stated goals?
As declared by the registrant: A Global Healthcare Company Dedicated to Providing a Suite of Innovative Hematology Products and Solutions Our comprehensive portfolio of devices, information management, and consulting services offers blood management solutions for each fa…
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 433002037182-07.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-06 · Commission Reuse Decision 2011/833/EU